Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum AGNC Investment Corp AGNC

Alternate Symbol(s):  AGNCN

Real Estate
AGNC Investment Corp. is an internally managed real estate investment trust (REIT). The Company provides private capital to the United States housing market, enhancing liquidity in the residential real estate mortgage markets and, in turn, facilitating home ownership in the United States. The Company invest primarily in Agency residential mortgage-backed securities (Agency RMBS) on a leveraged... see more

NDAQ:AGNC - Post Discussion

AGNC Investment Corp > AGN.c CEO Chris Moreau discussing Phase 2 of the Yale clinic
View:
Post by stockpatrol on Nov 02, 2022 6:05pm

AGN.c CEO Chris Moreau discussing Phase 2 of the Yale clinic

AGN.c CEO Chris Moreau discussing Phase 2 of the Yale clinical trial for DMT. 
 
https://www.youtube.com/watch?app=desktop&v=7iXLVqZleKo&ab_channel=RadiusResearch
 
AGN and Yale retain the intellectual property from the trials, AGN is supplying their new form of DMT. The additional data from these trials will assist AGN's ongoing DMT trials for treating strokes.
Be the first to comment on this post
AGNC Investment Corp